Cargando…
Discovery of SIRT7 Inhibitor as New Therapeutic Options Against Liver Cancer
Optimal therapeutic strategies for liver cancer patients remain challenging due to the high recurrence rate after surgical resection and chemotherapy resistance. Emerging evidence has shown that epigenetic factor SIRT7 is involved in various aspects of cancer biology, while inactive SIRT7 reverses h...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841758/ https://www.ncbi.nlm.nih.gov/pubmed/35174171 http://dx.doi.org/10.3389/fcell.2021.813233 |